Erratum: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein (Oncotarget (2017) 8 (14359-14373) DOI: 10.18632/oncotarget.8736);Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein

Oncotarget

Volumn 8, Issue 9, 2017, Pages 14359-14373

  Sheng, Weiwei ^a   Dong, Ming ^a   Chen, Chuanping ^b   Li, Yang ^a   Liu, Qingfeng ^c   Dong, Qi ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shenyang Eye Research Institute   (China)

^c People's Hospital of Liaoning Province   (China)

Author keywords

Invasion and metastasis; Musashi2; Numb; Pancreatic cancer

Indexed keywords

MESSENGER RNA; MUSASHI2 PROTEIN; NUMB PROTEIN; REGULATOR PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TUMOR VOLUME; UPREGULATION;

EID: 85014119382     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/ONCOTARGET.28157     Document Type: Erratum

References (33)

1. Lo Re G, Santeufemia DA, Foltran L, Bidoli E, Basso SM, Lumachi F. Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experience. Oncotarget. 2015; 6:8255-60. doi: 10.18632/oncotarget.3143.
2. H. Okano, T. Imai, M. Okabe. Musashi: a translational regulator of cell fate, J. Cell Sci. 2002; 115;1355-1359.
3. de Andres-Aguayo L, Varas F, Graf T. Musashi 2 in hematopoiesis. Curr Opin Hematol. 2012; 19: 268-72.
4. Glazer RI, Wang XY, Yuan H, Yin Y. Musashi1: a stem cell marker no longer in search of a function. Cell Cycle. 2008; 7: 2635-9.
5. Okano H, Kawahara H, Toriya M, Nakao K, Shibata S, Imai T. Function of RNA-binding protein Musashi-1 in stem cells, Exp. Cell. Res 2005; 306: 349-356.
6. Wuebben EL, Mallanna SK, Cox JL, Rizzino A. Musashi2 is required for the self-renewal and pluripotency of embryonic stem cells. PLoS One. 2012; 7:e34827.
7. Byers RJ, Currie T, Tholouli E, Rodig SJ, Kutok JL. MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia. Blood 2011; 118: 2857-2867.
8. Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, et al. Regulation of myeloid leukaemia by the cellfate determinant Musashi. Nature 2010; 466: 765-768.
9. He L, Zhou X, Qu C, Hu L, Tang Y, Zhang Q, Liang M, Hong J. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epitheli al-mesenchymal transition [J] J. Cell. Mol. Med. 2014; 184: 9-58.
10. Emadi-Baygi M, Nikpour P, Mohammad-Hashem F, Maracy MR, Haghjooy-Javanmard S. MSI2 expression is decreased in grade II of gastric carcinoma. Pathology-Research and Practice, 2013; 209: 689-691.
11. Cox JL, Wilder PJ, Gilmore JM, Wuebben EL, Washburn MP, Rizzino A. The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. PLoS One. 2013; 8:e62857.
12. Uemura T, Shepherd S, Ackerman L, Jan LY, Jan YN. Numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos. Cell 1989; 58:349-60.
13. Gulino A, Di Marcotullio L, Screpanti I. The multiple functions of Numb. Exp Cell Res, 2010; 316: 900-6.
14. Sheng W, Dong M, Zhou J, Li X, Liu Q, Dong Q, Li F. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer. Cell Tissue Res. 2013; 354:521-32.
15. Imai T, Tokunaga A, Yoshida T, Hashimoto M, Mikoshiba K, Weinmaster G, Nakafuku M, Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol. 2001; 21:3888-900.
16. Kharas MG1, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S, Morgan K, Tam W, Paktinat M, Okabe R, Gozo M, Einhorn W, Lane SW, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med 2010; 16:903-8.
17. Park JB, Kim YH, Kim J, Chang HM, Kim TW, Kim SC, Kim PN, Han DJ. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. J Vasc Interv Radiol. 2012; 23:635-41.
18. Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000; 6:4064-8.
19. Sheng W, Chen C, Dong M, Zhou J, Liu Q, Dong Q, Li F. Overexpression of Calreticulin Contributes to the Development and Progression of Pancreatic Cancer. J Cell Physiol. 2014; 229:887-97.
20. Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, Iscove NN, Sauvageau G. An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell. 2010; 2; 7:101-13.
21. Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Breast Cancer Res Treat. 2010; 122:315-24.
22. Colaluca IN, Tosoni D, Nuciforo P, Senic-Matuglia F, Galimberti V, Viale G, Pece S, Di Fiore PP. NUMB controls p53 tumour suppressor activity. Nature, 2008; 451:76-80.
23. Wang MH1, Qin SY, Zhang SG, Li GX, Yu ZH, Wang K, Wang B, Teng MJ, Peng ZH. Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway. Am J Cancer Res. 2015; 5:1089-100.
24. Moreira AL, Gonen M, Rekhtman N, Downey RJ. Progenitor stem cell marker expression by pulmonary carcinomas. Modern Pathology 2010; 23: 889-895.
25. Thol F, Winschel C, Sonntag AK, Damm F, Wagner K, Chaturvedi A, Göhring G, Schlegelberger B, Lübbert M, Fiedler W, Kirchner H, Krauter J, Ganser A, Heuser M. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia. Ann Hematol. 2013; 92:315-23.
26. Pereira JK, Traina F, Machado-Neto JA, Duarte Ada S, Lopes MR, Saad ST, Favaro P. Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients. Leuk Res. 2012; 36:1300-3.
27. Maiorano E, Favia G, Pece S, Resta L, Maisonneuve P, Di Fiore PP, Capodiferro S, Urbani U, Viale G. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas. Int. J. Int J Immunopathol Pharmacol, 2007; 20:779-89.
28. Stocken DD, Hassan AB, Altman DG, Billingham LJ, Bramhall SR, Johnson PJ, Freemantle N. Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer. 2008; 99:883-93.
29. Griner LN, Reuther GW. Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway. Cancer Biol Ther. 2010; 10:979-82.
30. Nishimoto Y, Okano H. New insight into cancer therapeutics: induction of differentiation by regulating the Musashi/Numb/Notch pathway. Cell Res. 2010; 20:1083-5.
31. Hong J, Liu Z, Zhu H, Zhang X, Liang Y, Yao S, Wang F, Xie X, Zhang B, Tan T, Fu L, Nie J, Cheng C. The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma. Oncotarget. 2014; 5:5602-14. doi: 10.18632/oncotarget.2136.
32. Pece S, Confalonieri S, R Romano P, Di Fiore PP. NUMBing down cancer by more than just a NOTCH. Biochim Biophys Acta. 2011; 1815:26-43.
33. Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, de Narvajas AA, Gomez TS, Simeone DM, Bujanda L, Billadeau DD. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis. 2013; 2:e61.